Quality of life (QOL) impact of adjuvant chemotherapy for early stage non- small cell lung cancer (NSCLC): Final analysis of JBR.10 randomized trial

被引：0
|
作者：
Bezjak, A.
Lee, C. W.
Ding, K.
Winton, T.
Brundage, M.
Graham, B.
Whitehead, M.
Seymour, L.
Shepherd, F. A.
机构：
[1] Princess Margaret Hosp, Toronto, ON, Canada
[2] BC Canc Agcy, Vancouver, BC, Canada
[3] NCIC CTG, Kingston, ON, Canada
[4] Univ Alberta Hosp, Edmonton, ON, Canada
[5] Kingston Reg Canc Ctr, Kingston, ON, Canada
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
7585
引用
收藏
页数：2
相关论文
共 50 条
  • [1] A Q-TWiST analysis of adjuvant chemotherapy in non-small cell lung cancer (NSCLC) in the NCIC CTG JBR.10 trial
    Jang, R. W.
    Le Maitre, A.
    Ding, K.
    Winton, T. L.
    Bezjak, A.
    Seymour, L.
    Shepherd, F. A.
    Leighl, N. B.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [2] The significance of K-ras mutations in the Intergroup JBR.10 Trial on adjuvant chemotherapy in completely resected early stage non-small cell lung cancer (NSCLC) patients
    Tsao, M
    Zhu, C
    Livingston, R
    Johnson, D
    Gandara, D
    Viallet, J
    Ding, K
    Seymour, L
    Winton, T
    Shepherd, F
    LUNG CANCER, 2005, 49 : S41 - S41
  • [3] Impact of hemoglobin levels on outcomes of adjuvant chemotherapy in resected non-small cell lung cancer: The JBR.10 trial experience
    Gauthier, I.
    Ding, K.
    Winton, T.
    Shepherd, F. A.
    Livingston, R.
    Johnson, D. H.
    Rigas, J. R.
    Whitehead, M.
    Graham, B.
    Seymour, L.
    LUNG CANCER, 2007, 55 (03) : 357 - 363
  • [4] Quality-of-Life Outcomes for Adjuvant Chemotherapy in Early-Stage Non-Small-Cell Lung Cancer: Results From a Randomized Trial, JBR. 10
    Bezjak, Andrea
    Lee, Christopher W.
    Ding, Keyue
    Brundage, Michael
    Winton, Timothy
    Graham, Barbara
    Whitehead, Marlo
    Johnson, David H.
    Livingston, Robert B.
    Seymour, Lesley
    Shepherd, Frances A.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (31) : 5052 - 5059
  • [5] A COST-EFFECTIVENESS ANALYSIS OF THE 15-GENE EXPRESSION SIGNATURE IN GUIDING ADJUVANT CHEMOTHERAPY IN EARLY STAGE NON-SMALL CELL LUNG CANCER BASED ON THE JBR.10 TRIAL
    Wong, Kit Man
    Li, Suzanne
    Ding, Keyue
    Bradbury, Penelope
    Tsao, Ming-Sound
    Shepherd, Frances A.
    Chung, Carmen
    Ng, Raymon
    Seymour, Lesley
    Leighl, Natasha B.
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S304 - S304
  • [6] An economic analysis of National Cancer Institute of Canada Clinical Trials Group (NCIC CTG) JBR.10, a randomized trial of adjuvant vinorelbine plus cisplatin versus observation in early stage non-small cell lung cancer (NSCLC).
    Ng, R.
    Mittmann, N.
    Florescu, M.
    Shepherd, F. A.
    Salvarrey, A.
    Seymour, L.
    Winton, T.
    Evans, B.
    Leighl, N.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 402S - 402S
  • [7] Pathologic determinants of survival for adjuvant treatment of stage IB non-small cell lung cancer (NSCLC): an analysis of the National Cancer Institute of Canada (NCIC) and Intergroup Study JBR.10
    Strevel, Elizabeth L.
    Ding, Keyue
    Seymour, Lesley
    Tsao, Ming S.
    Le Maitre, Aurelie
    Shepherd, Frances A.
    Burkes, Ronald L.
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S333 - S334
  • [8] Quality-Adjusted Time Without Symptoms or Toxicity Analysis of Adjuvant Chemotherapy in Non-Small-Cell Lung Cancer: An Analysis of the National Cancer Institute of Canada Clinical Trials Group JBR.10 Trial
    Jang, Raymond W.
    Le Maitre, Aurelie
    Ding, Keyue
    Winton, Tim
    Bezjak, Andrea
    Seymour, Lesley
    Shepherd, Frances A.
    Leighl, Natasha B.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (26) : 4268 - 4273
  • [9] Quality of life (QOL) and psychological support in non small cell lung cancer (NSCLC) patients: Results of a randomized trial
    Kritikos, Konstantinos
    Heras, Panagiotis
    Hatzopoulos, Antonios
    ANNALS OF ONCOLOGY, 2006, 17 : 299 - 300
  • [10] Updated survival analysis of JBR.10: A randomized phase III trial of vinorelbine/cisplatin versus observation in completely resected stage IB and II non-small cell lung cancer (NSCLC)
    Vincent, M. D.
    Butts, C.
    Seymour, L.
    Ding, K.
    Graham, B.
    Twumasi-Ankrah, P.
    Gandara, D.
    Schiller, J.
    Green, M.
    Shepherd, F.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
12345